Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12

References

• Achiron A, Feldman A, Mandel M, Gurevich M. 2007. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse. Ann N Y Acad Sci. 1107:155–167.
   PubMed Web of Science ®Google Scholar
• Adams J, Cory S. 2007. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol. 19:488–496.
   PubMed Web of Science ®Google Scholar
• Adams ME, Brown JW, Hitchcock S, Kikuchi S, Lam B, Monenschein H, Reichard H, Sun H. Takeda Pharmaceutical Company Limited. 2015 Aug 20. Pyrazines as modulators of GPR6. Japan WO2015123533A1.
   Google Scholar
• Aldieri E, Riganti C, Polimeni M, Gazzano E, Lussiana C, Campia I, Ghigo D. 2008. Classical inhibitors of NOX NAD(P)H oxidases are not specific. Curr Drug Metab. 9:686–696.
   PubMed Web of Science ®Google Scholar
• Alexander JJ, Anderson AJ, Barnum SR, Stevens B, Tenner AJ. 2008. The complement cascade: Yin-Yang in neuroinflammation-neuro-protection and -degeneration. J Neurochem. 107:1169–1187.
   PubMed Web of Science ®Google Scholar
• Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, Pawson AJ, Sharman JL, et al. 2017. The concise guide of pharmacology 2017/18: G protein-coupled receptors. Br J Pharmacol. 174:S17–S129.
   PubMed Web of Science ®Google Scholar
• Balleine B. 2005. Neural bases of food-seeking: affect, arousal and reward in corticostriatolimbic circuits. Physiol Behav. 86:717–730.
   PubMed Web of Science ®Google Scholar
• Balleine BW, Dickinson A. 1998. Goal-directed instrumental action: contingency and incentive learning and their cortical substrates. Neuropharmacology. 37:407–419.
   PubMed Web of Science ®Google Scholar
• Beeley NRA, Behan DP, Chalmers DT, Menzaghi F, Strah-Pleynet S. Arena Pharmaceuticals, Inc. 2001 Aug 30. Small molecule modulators of G protein-coupled receptor six. USA. WO2001062765A2.
   Google Scholar
• Benoit ME, Hernandez MX, Dinh ML, Benavente F, Vasquez O, Tenner AJ. 2013. C1q-induced LRP1B and GPR6 proteins expressed early in alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity. J Biol Chem. 288:654–665.
   PubMed Web of Science ®Google Scholar
• Benoit ME, Tenner AJ. 2011. Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci. 31:3459–3469.
   PubMed Web of Science ®Google Scholar
• Bjursell M, Gerdin AK, Jönsson M, Surve VV, Svensson L, Huang XF, Törnell J, Bohlooly Y-M. 2006. G protein-coupled receptor 12 deficiency results in dyslipidemia and obesity in mice. Biochem Biophys Res Commun. 348:359–366.
   PubMed Web of Science ®Google Scholar
• Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Jaw KC, Dun NJ. 2007. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology. 148:5088–5094.
   PubMed Web of Science ®Google Scholar
• Brennand JC, Charles AD, Hart KA. AstraZeneca. 2001 Jul 5. Method for screening of appetite control agents. Germany. WO2001048483A2.
   Google Scholar
• Brown J, Hitchcock S, Hopkins M, Kikuchi S, Monenschein H, Reichard H, Schleicher K, Sun H, Macklin T. Takeda Pharmaceutical Company Limited. 2015 Jun 25. Tetrahydropyridopyrazines as modulators of GPR6. Japan. WO2015095728A1.
   Google Scholar
• Brown KJ, Laun AS, Song Z-H. 2017. Cannabidiol, a novel inverse agonist for GPR12. Biochem Biophys Res Commun. 493:451–454.
   PubMed Web of Science ®Google Scholar
• Cai D, Qiu J, Cao Z, McAtee M, Bregman BS, Filbin MT. 2001. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci. 21:4731–4739.
   PubMed Web of Science ®Google Scholar
• Cai D, Yingjing S, De Bellard ME, Tang S, Filbin MT. 1999. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron. 22:89–101.
   PubMed Web of Science ®Google Scholar
• Calabresi P, Filippo MD, Ghiglieri V, Tambasco N, Picconi B. 2010. Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. Lancet Neurol. 9:1106–1117.
   PubMed Web of Science ®Google Scholar
• Carlton M, Dixon J, Hendrick A, Messager S, Zahn D, Horwood JM. Paradigm Therapeutics Limited. 2006 Mar 31. Sphingosylphosphorylcholine receptor GPR12, GPR12 knockout animals for the neuronal and limbic system drug screening, and therapeutic and diagnostic uses. UK. WO 2005027628.
   Google Scholar
• Collins AGE, Frank MJ. 2012. How much of reinforcement learning is working memory, not reinforcement learning? A behavioral, computational, and neurogenetic analysis. Eur J Neurosci. 35:1024–1035.
   PubMed Web of Science ®Google Scholar
• Coyle PK. 2017. Pharmacogenetic biomarkers to predict treatment response in multiple sclerosis: current and future perspectives. Multiple Sclerosis Int. 2017:1–33.
   Google Scholar
• DiLuigi A, Weitzman VN, Pace MC, Siano LJ, Maier D, Mehlmann LM. 2008. Meiotic arrest in human oocytes is maintained by a Gs signaling pathway. Biol Reprod. 78:667–672.
   PubMed Web of Science ®Google Scholar
• Dore R, Levata L, Lehnert H, Schulz C. 2017. Nesfatin-1: functions and physiology of a novel regulatory peptide. J Endocrinol. 232:R45–R65.
   PubMed Web of Science ®Google Scholar
• Eggerickx D, Denef JF, Labbe O, Hayashi Y, Refetoff S, Vassart G, Parmentier M, Libert F. 1995. Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase. Biochem J. 309:837–843.
   PubMed Web of Science ®Google Scholar
• Frank E, Wu Y, Piyaratna N, Body WJ, Snikeris P, South T, Gerdin AK, Bjursell M, Bohlooly Y-M, Storlien L, et al. 2012. Metabolic parameters and emotionality are little affected in G-protein coupled receptor 12 (Gpr12) mutant mice. PLoS One. 7:e42395–e42398.
   PubMed Web of Science ®Google Scholar
• Frank MJ, Fossella JA. 2011. Neurogenetics and pharmacology of learning, motivation, and cognition. Neuropsychopharmacol. 36:133–152.
   PubMed Web of Science ®Google Scholar
• Fredriksson R, Lagerström MC, Lundin L-G, Schiöth HB. 2003. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 63:1256–1272.
   PubMed Web of Science ®Google Scholar
• Fredriksson R, Schio HB. 2005. The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol. 67:1414–1425.
   PubMed Web of Science ®Google Scholar
• Freudzon L, Norris RP, Hand AR, Tanaka S, Saeki Y, Jones TLZ, Rasenick MM, Berlot CH, Mehlmann LM, Jaffe LA. 2005. Regulation of meiotic prophase arrest in mouse oocytes by GPR3, a constitutive activator of the Gs G protein. J Cell Biol. 171:255–265.
   PubMed Web of Science ®Google Scholar
• Gao Y, Nikulina E, Mellado W, Filbin MT. 2003. Neurotrophins elevate cAMP to reach a threshold required to overcome inhibition by MAG through extracellular signal-regulated kinase-dependent inhibition of phosphodiesterase. J Neurosci. 23:11770–11777.
   PubMed Web of Science ®Google Scholar
• Godlewski G, Jourdan T, Szanda G, Tam J, Resat C, Harvey-White J, Liu J, Mukhopadhyay B, Pacher P, Ming Mo F, et al. 2015. Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissue. Sci Rep. 5:14953.
   PubMed Web of Science ®Google Scholar
• Graber JJ, Dhib-Jalbut S. 2011. Biomarkers of disease activity in multiple sclerosis. J Neurol Sci. 305:1–10.
   PubMed Web of Science ®Google Scholar
• Hecker M, Paap BK, Goertsches RH, Kandulski O, Fatum C, Koczan D, Hartung HP, Thiesen HJ, Zettl UK. 2011. Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis. PLoS One. 6:e29648.
   PubMed Web of Science ®Google Scholar
• Heiber M, Docherty JM, Shah G, Nguyen T, Cheng R, Heng HHQ, Márchese A, Tsui L-C, Shi X, George SR, et al. 1995. Isolation of three novel human genes encoding G protein-coupled receptors. DNA Cell Biol. 14:25–35.
   PubMed Web of Science ®Google Scholar
• Heiman M, Schaefer A, Gong S, Peterson JD, Day M, Ramsey KE, Suárez-Fariñas M, Schwarz C, Stephan DA, Surmeier DJ, et al. 2008. A translational profiling approach for the molecular characterization of CNS cell types. Cell. 135:738–748.
   PubMed Web of Science ®Google Scholar
• Hinckley M, Vaccari S, Horner K, Chen R, Conti M. 2005. The G-protein-coupled receptors GPR3 and GPR12 are involved in cAMP signaling and maintenance of meiotic arrest in rodent oocytes. Dev Biol. 287:249–261.
   PubMed Web of Science ®Google Scholar
• Hitchcock S, Hopkins M, Kikuchi S, Monenschein H, Reichard H, Sun H, Macklin T. Takeda Pharmaceutical Company Limited,. 2015 Aug 20. Pyridopyrazines modulators of GPR6. Japan. WO2015123505A1.
   Google Scholar
• Hitchcock S, Monenschein H, Reichard H, Sun H, Kikuchi S, Macklin T, Hopkins M. Envoy Therapeutics, Inc. 2014 20. Quinoxaline derivatives as GPR6 modulators. USA. WO2014028479A1.
   Google Scholar
• Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, et al. 2006. Regional and cellular gene expression changes in human Huntington’s disease brain. Hum Mol Genet. 15:965–977.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Merchiers PG, Spittaels KFF, Galapagos NV. 2006 Nov 3. Methods, compositions and compound assays for inhibiting amyloid-beta protein production. Belgium. WO2005103713A3.
   Google Scholar
• Howell GR, Macalinao DG, Sousa GL, Walden M, Soto I, Kneeland SC, Barbay JM, King BL, Marchant JK, Hibbs M, et al. 2011. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 121:1429–1444.
   PubMed Web of Science ®Google Scholar
• Huang Y, Skwarek-Maruszewska A, Horre K, Vandewyer E, Wolfs L, Snellinx A, Saito T, Radaelli E, Corthout N, Colombelli J, et al. 2015. Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer’s disease mouse models. Sci Transl Med. 7:309ra164.
   PubMed Web of Science ®Google Scholar
• Ignatov A, Lintzel J, Hermans-Borgmeyer I, Kreienkamp H-J, Joost P, Thomsen S, Methner A, Schaller HC. 2003a. Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development. J Neurosci. 23:907–914.
   PubMed Web of Science ®Google Scholar
• Ignatov A, Lintzel J, Kreienkamp H-J, Chica Schaller H. 2003b. Sphingosine-1-phosphate is a high-affinity ligand for the G protein-coupled receptor GPR6 from mouse and induces intracellular Ca2+ release by activating the sphingosine-kinase pathway. Biochem Biophys Res Commun. 311:329–336.
   PubMed Web of Science ®Google Scholar
• Isawi I, Morales P, Laun A, Hurst D, Song ZH, Reggio P. 2017. Towards a structural understanding of the orphan receptor GPR6: relationship with the cannabinoids. Southeastern Regional Meeting of the American Chemical Society; Nov 7–11; Charlotte, NC.
   Google Scholar
• Jankovic J. 2008. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 79:368–376.
   PubMed Web of Science ®Google Scholar
• Jensen T, Elster L, Nielsen SM, Poda SB, Loechel F, Volbracht C, Klewe IV, David L, Watson SP. 2014. The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function. Bioorg Med Chem Lett. 24:5195–5198.
   PubMed Web of Science ®Google Scholar
• Kalinowski RR, Berlot CH, Jones TLZ, Ross LF, Jaffe LA, Mehlmann LM. 2004. Maintenance of meiotic prophase arrest in vertebrate oocytes by a G s protein-mediated pathway. Dev Biol. 267:1–13.
   PubMed Web of Science ®Google Scholar
• Karran E, Mercken M, De Strooper B. 2011. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 10:698–712.
   PubMed Web of Science ®Google Scholar
• Khodosevich K, Monyer H. 2010. Signaling involved in neurite outgrowth of postnatally born subventricular zone neurons in vitro. BMC Neurosci. 11:18–11.
   PubMed Web of Science ®Google Scholar
• Kokubo M, Nishio M, Ribar TJ, Anderson KA, West AE, Means AR. 2009. BDNF-mediated cerebellar granule cell development is impaired in mice null for CaMKK2 or CaMKIV. J Neurosci. 29:8901–8913.
   PubMed Web of Science ®Google Scholar
• Komatsu H, Maruyama M, Yao S, Shinohara T, Sakuma K, Imaichi S, Chikatsu T, Kuniyeda K, Siu FK, Peng LS, et al. 2014. Anatomical transcriptome of G protein-coupled receptors leads to the identification of a novel therapeutic candidate gpr52 for psychiatric disorders. PLoS One. 9:e90134.
   PubMed Web of Science ®Google Scholar
• Kouser L, Madhukaran SP, Shastri A, Saraon A, Ferluga J, Al-Mozaini M, Kishore U. 2015. Emerging and novel functions of complement protein C1q. Front Immunol. 6:317.
   PubMed Web of Science ®Google Scholar
• Kovanci E, Simpson JL, Amato P, Rohozinski J, Heard MJ, Bishop CE, Carson SA. 2008. Oocyte-specific G-protein-coupled receptor 3 (GPR3): no perturbations found in 82 women with premature ovarian failure (first report). Fertil Steril. 90:1269–1271.
   PubMed Web of Science ®Google Scholar
• Kreitzer AC, Malenka RC. 2008. Striatal plasticity and basal ganglia circuit function. Neuron. 60:543–554.
   PubMed Web of Science ®Google Scholar
• LaFerla FM, Green KN, Oddo S. 2007. Intracellular amyloid-beta in Alzheimer’s disease . Nat Rev Neurosci. 8:499–509.
   PubMed Web of Science ®Google Scholar
• Laun AS, Song Z-H. 2017. GPR3 and GPR6, novel molecular targets for cannabidiol. Biochem Biophys Res Commun. 490:17–21.
   PubMed Web of Science ®Google Scholar
• Le Gras S, Keime C, Anthony A, Lotz C, De Longprez L, Brouillet E, Cassel J-C, Boutillier A-L, Merienne K. 2017. Altered enhancer transcription underlies Huntington’s disease striatal transcriptional signature. Sci Rep. 7:42875.
   PubMed Web of Science ®Google Scholar
• Ledent C, Demeestere I, Blum D, Petermans J, Hämäläinen T, Smits G, Vassart G. 2005. Premature ovarian aging in mice deficient for GPR3. Proc Natl Acad Sci USA. 102:8922–8926.
   PubMed Web of Science ®Google Scholar
• Li R, Albertini DF. 2013. The road to maturation: somatic cell interaction and self-organization of the mammalian oocyte. Nat Rev Mol Cell Biol. 14:141–152.
   PubMed Web of Science ®Google Scholar
• Lin Z-J, Lu X-M, Zhu T-J, Fang Y-C, Gu Q-Q, Zhu W. 2008. GPR12 Selections of the metabolites from an endophytic Streptomyces sp. associated with Cistanches deserticola. Arch Pharm Res. 31:1108–1114.
   PubMed Web of Science ®Google Scholar
• Lobo MK, Cui Y, Ostlund SB, Balleine BW, Yang XW. 2007. Genetic control of instrumental conditioning by striatopallidal neuron-specific S1P receptor Gpr6. Nat Neurosci. 10:1395–1397.
   PubMed Web of Science ®Google Scholar
• Lowther KM, Nikolaev VO, Mehlmann LM. 2011. Endocytosis in the mouse oocyte and its contribution to cAMP signaling during meiotic arrest. Reproduction. 141:737–747.
   PubMed Web of Science ®Google Scholar
• Lowther KM, Uliasz TF, Götz KR, Nikolaev VO, Mehlmann LM. 2013. Regulation of constitutive GPR3 signaling and surface localization by GRK2 and β-arrestin-2 overexpression in HEK293 cells. PLoS One. 8:e65365.
   PubMed Web of Science ®Google Scholar
• Lu X, Zhang N, Dong S, Hu Y. 2012a. Involvement of GPR12 in the induction of neurite outgrowth in PC12 cells. Brain Res Bull. 87:30–36.
   PubMed Web of Science ®Google Scholar
• Lu X, Zhang N, Meng B, Dong S, Hu Y. 2012b. Involvement of GPR12 in the regulation of cell proliferation and survival. Mol Cell Biochem. 366:101–110.
   PubMed Web of Science ®Google Scholar
• Martin AL, Steurer MA, Aronstam RS, Johnson EC. 2015. Constitutive activity among orphan class-A G protein coupled receptors. PLoS One. 10:e0138463.
   PubMed Web of Science ®Google Scholar
• Martire S, Navone ND, Montarolo F, Perga S, Bertolotto A. 2016. A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients. J Neuroimmunol. 292:34–39.
   PubMed Web of Science ®Google Scholar
• Massoud H, Medhat D, Eldeen ES, Khayat ZE, Osman MA. 2017. G protein coupled membrane receptor expression and IL-17A in multiple sclerosis. Biosci Res. 14:282–290.
   Google Scholar
• Mattson MP. 2004. Pathways towards and away from Alzheimer’s disease. Nature. 430:631–639.
   PubMed Web of Science ®Google Scholar
• Mehlmann LM. 2005. Oocyte-specific expression of Gpr3 is required for the maintenance of meiotic arrest in mouse oocytes. Dev Biol. 288:397–404.
   PubMed Web of Science ®Google Scholar
• Mehlmann LM, Jones TLZ, Jaffe LA. 2002. Meiotic arrest in the mouse follicle maintained by a Gs protein in the oocyte. Science. 297:1343–1345.
   PubMed Web of Science ®Google Scholar
• Mehlmann LM, Saeki Y, Tanaka S, Brennan TJ, Evsikov AV, Pendola FL, Knowles BB, Eppig JJ, Jaffe LA. 2004. The Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes. Science. 306:1947–1950.
   PubMed Web of Science ®Google Scholar
• Melchior B, Garcia AE, Hsiung B-K, Lo KM, Doose JM, Thrash JC, Stalder AK, Staufenbiel M, Neumann H, Carson MJ. 2010. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer’s disease. ASN Neuro. 2:AN20100010–AN20100170.
   Web of Science ®Google Scholar
• Miyagi T, Tanaka S, Hide I, Shirafuji T, Sakai N. 2016. The subcellular dynamics of the Gs-linked receptor GPR3 contribute to the local activation of PKA in cerebellar granular neurons. PLoS One. 11:e0147466.
   PubMed Web of Science ®Google Scholar
• Morales P, Hurst DP, Reggio PH. 2017a. Methods for the development of in silico GPCR models. In: Reggio PH, editor. Cannabinoids and their receptors. Methods in enzymology. London, UK: Elsevier; p. 405–448.
   Google Scholar
• Morales P, Hurst DP, Reggio PH. 2017b. Molecular targets of the phytocannabinoids: a complex picture. In: Kinghorn AD, Gibbons S, editors. Progress in the Chemistry of Organic Natural Products 103. Cham, Switzerland: Springer International Publishing; p. 103–131.
   Google Scholar
• Mori M, Eguchi H. Teijin Pharma Limited. 2012 Jul 17. Screening GPR12 receptor for substances having Nesfatin-1-like action, or which regulate Nesfatin-1 action. Japan. US8221990B2.
   Google Scholar
• Nader N, Dib M, Daalis A, Kulkarni RP, Machaca K. 2014. Role for endocytosis of a constitutively active GPCR (GPR185) in releasing vertebrate oocyte meiotic arrest. Dev Biol. 395:355–366.
   PubMed Web of Science ®Google Scholar
• Oeckl P, Ferger B. 2016. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity. Neuroscience. 337:218–223.
   PubMed Web of Science ®Google Scholar
• Oeckl P, Hengerer B, Ferger B. 2014. G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson’s disease. Exp Neurol. 257:1–9.
   PubMed Web of Science ®Google Scholar
• Oh IS, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, et al. 2006. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 443:709–712.
   PubMed Web of Science ®Google Scholar
• Olanow CW, Tatton WG. 1999. Etiology and pathogenesis of Parkinson’s disease. Annu Rev Neurosci. 22:123–144.
   PubMed Web of Science ®Google Scholar
• Padmanabhan S, Myers AG, Prasad BM. 2009. Constitutively active GPR6 is located in the intracellular compartments. FEBS Lett. 583:107–112.
   PubMed Web of Science ®Google Scholar
• Patel KR, Cherian J, Gohil K, Atkinson D. 2014. Schizophrenia: overview and treatment options. Pharm Ther. 39:638–645.
   Google Scholar
• Pertwee RG, Howlett AC, Abood ME, Alexander SPH, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, et al. 2010. International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev. 62:588–631.
   PubMed Web of Science ®Google Scholar
• Peters M, Scott REM, Tully TP. Helicon Therapeutics, Inc. 2008 Nov 27. Methods of treating cognitive disorders by inhibition of Gpr12, and screening method for Gpr12 modulators. USA. WO2008144453A1.
   Google Scholar
• Pisalyaput K, Tenner AJ. 2008. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms. J Neurochem. 104:696–707.
   PubMed Web of Science ®Google Scholar
• Pisanti S, Malfitano AM, Ciaglia E, Lamberti A, Ranieri R, Cuomo G, Abate M, Faggiana G, Proto MC, Fiore D, et al. 2017. Cannabidiol: state of the art and new challenges for therapeutic applications. Pharmacol Ther. 175:133–150.
   PubMed Web of Science ®Google Scholar
• Prasad BM, Hollins B, Lambert NA. 2010. Methods to detect cell surface expression and constitutive activity of GPR6. In: Conn M, editor. Constitutive activity in receptors and other proteins, Part A. Methods in Enzymology. London, UK: Elsevier; p. 179–195.
   Google Scholar
• Raymond LA, André VM, Cepeda C, Gladding CM, Milnerwood AJ, Levine MS. 2011. Pathophysiology of Huntington’s disease: time-dependent alterations in synaptic and receptor function. Neuroscience. 198:252–273.
   PubMed Web of Science ®Google Scholar
• Regard JB, Sato IT, Coughlin SR. 2008. Anatomical profiling of G protein-coupled receptor expression. Cell. 135:561–571.
   PubMed Web of Science ®Google Scholar
• Reid KBM. 1983. Proteins involved in the activation and control of the two pathways of human complement. Biochem Soc Trans. 11:1–12.
   PubMed Web of Science ®Google Scholar
• Rios-Cardona D, Ricardo-Gonzalez RR, Chawla A, Ferrell JE. 2008. A role for GPRx, a novel GPR3/6/12-related G-protein coupled receptor, in the maintenance of meiotic arrest in Xenopus laevis oocytes. Dev Biol. 317:380–388.
   PubMed Web of Science ®Google Scholar
• Rogers NH, Landa A, Park S, Smith RG. 2012. Aging leads to a programmed loss of brown adipocytes in murine subcutaneous white adipose tissue. Aging Cell. 11:1074–1083.
   PubMed Web of Science ®Google Scholar
• Roos RA. 2010. Huntington’s disease: a clinical review. Orphanet J Rare Dis. 5:40.
   PubMed Web of Science ®Google Scholar
• Ruiz-Medina J, Ledent C, Valverde O. 2011. GPR3 orphan receptor is involved in neuropathic pain after peripheral nerve injury and regulates morphine-induced antinociception. Neuropharmacology. 61:43–50.
   PubMed Web of Science ®Google Scholar
• Saeki Y, Ueno S, Mizuno R, Nishimura T, Fujimura H, Nagai Y, Yanagihara T. 1993. Molecular cloning of a novel putative G protein-coupled receptor (GPCR21) which is expressed predominantly in mouse central nervous system. FEBS Lett. 336:317–322.
   PubMed Web of Science ®Google Scholar
• Sánchez F, Smitz J. 2012. Molecular control of oogenesis. Biochim Biophys Acta.1822:1896–1912.
   PubMed Web of Science ®Google Scholar
• Serrano A, Pavon FJ, Suarez J, Romero-Cuevas M, Baixeras E, Goya P, de Fonseca FR. 2012. Obesity and the endocannabinoid system: is there still a future for CB1 antagonists in obesity? Curr Obes Rep. 1:216–228.
   Google Scholar
• Song Z-H, Modi W, Bonner TI. 1995. Molecular cloning and chromosomal localization of human genes encoding three closely related G protein-coupled receptors. Genomics. 28:347–349.
   PubMed Web of Science ®Google Scholar
• Southern C, Cook JM, Neetoo-Isseljee Z, Taylor DL, Kettleborough CA, Merritt A, Bassoni DL, Raab WJ, Quinn E, Wehrman TS, et al. 2013. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. J Biomol Screen. 18:599–609.
   PubMedGoogle Scholar
• Tanaka S, Ishii K, Kasai K, Sung OY, Saeki Y. 2007. Neural expression of G protein-coupled receptors GPR3, GPR6, and GPR12 up-regulates cyclic AMP levels and promotes neurite outgrowth. J Biol Chem. 282:10506–10515.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Miyagi T, Dohi E, Seki T, Hide I, Sotomaru Y, Saeki Y, Antonio Chiocca E, Matsumoto M, Sakai N. 2014. Developmental expression of GPR3 in rodent cerebellar granule neurons is associated with cell survival and protects neurons from various apoptotic stimuli. Neurobiol Dis. 68:215–227.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Shaikh IM, Chiocca EA, Saeki Y. 2009. The Gs-linked receptor GPR3 inhibits the proliferation of cerebellar granule cells during postnatal development. PLoS One. 4:e5922.
   PubMed Web of Science ®Google Scholar
• Thathiah A, Horré K, Snellinx A, Vandewyer E, Huang Y, Ciesielska M, De Kloe G, Munck S, De Strooper B. 2013. β-Arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer’s disease. Nat Med. 19:43–49.
   PubMed Web of Science ®Google Scholar
• Thathiah A, Spittaels K, Hoffmann M, Staes M, Cohen A, Horré K, Vanbrabant M, Coun F, Baekelandt V, Delacourte A, et al. 2009. The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science. 323:946–951.
   PubMed Web of Science ®Google Scholar
• Tong L. 2004. B-Amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci. 24:6799–6809.
   PubMed Web of Science ®Google Scholar
• Torkildsen O, Myhr KM, Bø L. 2016. Disease-modifying treatments for multiple sclerosis – a review of approved medications. Eur J Neurol. 23:18–27.
   PubMed Web of Science ®Google Scholar
• Tourino C, Valjent E, Ruiz-Medina J, Herve D, Ledent C, Valverde O. 2012. The orphan receptor GPR3 modulates the early phases of cocaine reinforcement. Br J Pharmacol. 167:892–904.
   PubMed Web of Science ®Google Scholar
• Uhlenbrock K, Gassenhuber H, Kostenis E. 2002. Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cell Signal. 14:941–953.
   PubMed Web of Science ®Google Scholar
• Uhlenbrock K, Huber J, Ardati A, Busch AE, Kostenis E. 2003. Fluid shear stress differentially regulates gpr3, gpr6, and gpr12 expression in human umbilical vein endothelial cells. Cell Physiol Biochem.13:75–84.
   PubMed Web of Science ®Google Scholar
• Valverde O, Célérier E, Baranyi M, Vanderhaeghen P, Maldonado R, Sperlagh B, Vassart G, Ledent C. 2009. GPR3 receptor, a novel actor in the emotional-like responses. PLoS One. 4:e4704.
   PubMed Web of Science ®Google Scholar
• Vosoughi R, Freedman MS. 2010. Therapy of MS. Clin Neurol Neurosurg. 112:365–385.
   PubMed Web of Science ®Google Scholar
• Waalen J, Buxbaum JN. 2011. Is older colder or colder older? The association of age with body temperature in 18,630 individuals. J Gerontol A Biol Sci Med Sci. 66:487–492.
   PubMed Web of Science ®Google Scholar
• Wang H, Farhan M, Xu J, Lazarovici P, Zheng W. 2017. The involvement of DARPP-32 in the pathophysiology of schizophrenia. Oncotarget. 8:53791–53803.
   PubMedGoogle Scholar
• Watt G, Karl T. 2017. In vivo evidence for therapeutic properties of cannabidiol (CBD) for Alzheimer’s disease. Front Pharmacol. 8:20–27.
   PubMed Web of Science ®Google Scholar
• Yang CR, Wei Y, Qi ST, Chen L, Zhang QH, Ma JY, Luo YB, Wang YP, Hou Y, Schatten H, et al. 2012. The G protein coupled receptor 3 is involved in cAMP and cGMP signaling and maintenance of meiotic arrest in porcine oocytes. PLoS One. 7:e38807.
   PubMed Web of Science ®Google Scholar
• Yao Z, Spriggs MK, Derry JM, Strockbine L, Park LS, VandenBos T, Zappone JD, Painter SL, Armitage RJ. 1997. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine. 9:794–800.
   PubMed Web of Science ®Google Scholar
• Ye C, Zhang Z, Wang Z, Hua Q, Zhang R, Xie X. 2014. Identification of a novel small-molecule agonist for human G protein-coupled receptor 3. J Pharmacol Exp Ther. 349:437–443.
   PubMed Web of Science ®Google Scholar
• Yin H, Chu A, Li W, Wang B, Shelton F, Otero F, Nguyen DG, Caldwell JS, Chen YA. 2009. Lipid G protein-coupled receptor ligand identification using β-Arrestin PathHunter™ assay. J Biol Chem. 284:12328–12338.
   PubMed Web of Science ®Google Scholar
• Zhang B-L, Li Y, Ding J-H, Dong F-L, Hou Y-J, Jiang B-C, Shi F-X, Xu Y-X. 2012. Sphingosine 1-phosphate acts as an activator for the porcine Gpr3 of constitutively active G protein-coupled receptors. J Zhejiang Univ Sci B. 13:555–566.
   PubMed Web of Science ®Google Scholar
• Zhou S, Wang B, Ni F, Wang J, Cao Y, Ma X. 2010. GPR3 may not be a potential candidate gene for premature ovarian failure. Reprod BioMed Online. 20:53–55.
   PubMed Web of Science ®Google Scholar